Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The primary objective of the study was to evaluate the safe and effective use of the single-use autoinjector for the intramuscular (IM) delivery of liquid Avonex® (interferon beta-1a) in participants with multiple sclerosis (MS).
Epistemonikos ID: c4a37e1577c6b1e9a860568999b8f450580adcea
First added on: May 05, 2024